Filing Flows › Nutra Pharma (NPHC) › Q2 2026 › vs Q1 2026
Nutra Pharma (NPHC) Q2 2026 vs Q1 2026 (quarter over quarter)
Nutra Pharma's revenue rose $7K (+26%) from $27K in Q1 2026 to $34K in Q2 2026.
Nutra Pharma, Q2 2026: revenue $34K (-59% year over year), net loss $3.9M, operating cash flow −$251K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $34K | $27K | $7K | +26% |
| Net loss | $3.9M | $460K | $3.5M | +759% |
| Costs & expenses | $4.0M | $487K | $3.5M | +718% |
| Operating costs | $470K | $406K | $63K | +16% |
| Interest & other, net | $3.5M | $80K | $3.4M | 44× |
| Cost of revenue | $2K | $8K | −$6K | -78% |
| Operating expenses | $468K | $398K | $70K | +18% |
| Operating cash sources | $3.9M | $460K | $3.5M | +759% |
| Depreciation | $2K | $3K | −$143 | -6% |
| Share-based compensation | $4K | $11K | −$8K | -68% |
| Working capital & other | $3.7M | $118K | $3.6M | 31× |
| Cash used in operations | $251K | $328K | −$77K | -23% |
| Net loss absorbed | $3.9M | $460K | $3.5M | +759% |
Questions
How much did Nutra Pharma's revenue grow quarter over quarter in Q2 2026?
Nutra Pharma's revenue rose $7K (+26%) from $27K in Q1 2026 to $34K in Q2 2026.